Plavix

This page contains recent news articles, when available, and an overview of Plavix but does not offer medical advice. You should contact your physician with regard to any health issues or concerns.


Overview:

Plavix
(when available)

Pharmacology and use:
Clopidogrel, an antiplatelet agent structurally and pharmacologically similar to ticlopidine, is used to reduce atherosclerotic events such as myocardial infarction, stroke, and vascular death in patients who have had a recent stroke, recent MI, or have established peripheral vascular disease. For the reduction of atherosclerotic events (myocardial infarction, stroke, and vascular death) in patients with atherosclerosis documented by recent stroke, recent myocardial infarction, or established peripheral arterial disease

Mechanism Of Action:
The active metabolite of Clopidogrel prevents binding of adenosine diphosphate (ADP) to its platelet receptor, impairing the ADP-mediated activation of the glycoprotein GPIIb/IIIa complex. It is proposed that the inhibition involves a defect in the mobilization from the storage sites of the platelet granules to the outer membrane. No direct interference occurs with the GPIIb/IIIa receptor. As the glycoprotein GPIIb/IIIa complex is the major receptor for fibrinogen, its impaired activation prevents fibrinogen binding to platelets and inhibits platelet aggregation. By blocking the amplification of platelet activation by released ADP, platelet aggregation induced by agonists other than ADP is also inhibited by the active metabolite of Clopidogrel.

News Articles on Clopidogrel

Two new blood thinners better than Plavix and warfarin, studies say  -  30 Aug 2009
Two new blood thinners are better at preventing clots, heart attacks, strokes and death than two widely used drugs, Plavix and warfarin, Los Angeles Times

New Anti-Clotting Drug Beats Plavix  -  30 Aug 2009
30 (HealthDay News) -- A new anti-clotting drug, ticagrelor (Brilinta), was better than than clopidogrel (Plavix) in preventing new heart attacks and in Atlanta Journal Constitution

New Large-Scale, Global Study Provides Additional Information ...  -  30 Aug 2009
CURRENT-OASIS 7 is the largest clinical trial (25087 patients) to evaluate different dosing regimens of PLAVIX ® plus aspirin in a broad range of acute WELT ONLINE

astrazeneca's Blood Thinner More Effective Than Plavix In Study ...  -  30 Aug 2009
...s (NYSE:BMY) Plavix in a study. The drug prevented 16% more heart attacks, strokes, and deaths. The findings position Brilinta to rival Plavix, Trading Markets (press release)

Study could boost new Astra-Zeneca drug  -  30 Aug 2009
Clopidogrel is sold under the trade name Plavix by Bristol-Meyers Squibb and Sanofi Aventis . "A similar benefit was seen for the individual components of MarketWatch

Doubling clopidogrel dose in ACS  -  30 Aug 2009
Barcelona, Spain - Doubling the loading and maintenance doses of clopidogrel (Plavix, Bristol-Myers Squibb/Sanofi-Aventis) in ACS patients undergoing TheHeart.Org

'Worried well' should not take aspirin to ward off heart attack  -  30 Aug 2009
...their risk of dying from heart disease by 21 per cent compared with those taking the current “gold-standard� drug, clopidogrel (Plavix), researchers found. Times Online

Business in the courts  -  30 Aug 2009
Paris-based Sanofi-Aventis is under pressure as several of its best-selling drugs, including the blood thinner Plavix, face generic competition. The News Journal

Donating plasma can help save lives  -  30 Aug 2009
Donors taking Plavix or Ticlid must wait at least 15 days after their last dose before donating platelets. Platelets can be donated as often as every seven phillyBurbs.com

Plavix Less Effective In Certain Patients - Study  -  ‎Aug 26, 2009‎
The study confirms earlier research suggesting that the 30% of the population who has the gene variation responds less effectively to Plavix, Wall Street Journal

US Patent Office Orders Re-Exam Of Plavix Patent  -  ‎Aug 19, 2009‎
A lawyer for Canadian generics manufacturer Apotex Inc. had requested the re-exam in June, saying that certain drug research conducted prior to the Plavix Wall Street Journal

US EQUITIES WEEK AHEAD: Aug Jobs Data, Auto, Retail Sales Due  -  ‎Aug 28, 2009‎
In one study of about 25000 patients, researchers tested whether a higher-than-normal dose of blood thinner Plavix was any better than the standard dose at Wall Street Journal

Plavix Ineffectiveness Predicted By Gene Variant Found in One of ...  -  ‎Aug 27, 2009‎
Plavix (clopidogrel) is a blood thinner that prevents blood platelets from sticking together to form clots. It is prescribed to prevent heart attacks, AboutLawsuits.com

Wait for Medication, Including Cancer Drugs, in UK Distresses Patients  -  ‎Aug 24, 2009‎
In another case, a shortage of the blood clot drug Plavix had resulted in a hospital admission, it was claimed. Nearly 90 percent of those who took part in FOXNews

New Blood Thinners in the Spotlight at Heart Meeting  -  ‎Aug 28, 2009‎
In May, AZ announced that Brilinta was statistically superior to Plavix in preventing cardiovascular events in patients with acute coronary syndrome, Wall Street Journal Blogs

Plavix Pharmacogenomics: To Test or Not to Test?  -  ‎Aug 27, 2009‎
To recap, it seems that people with one of the variants of the CYP2C19 polymorphism are poor metabolizers of Plavix; clopidogrel is inactive as ingested, The IN VIVO Blog

Bristol-Myers Squibb downgraded on share price  -  ‎Aug 28, 2009‎
Shares of Bristol-Myers, which makes the blockbuster blood-thinner Plavix, are up almost 20 percent since mid-July and are trading close to annual highs. Forbes

Acino Gets EU OK To Sell Generic Plavix In 4 Countries  -  ‎Aug 4, 2009‎
EB) said Tuesday it has received regulatory approval to sell its generic version of blood thinner Plavix in four European countries. Wall Street Journal

Women More Prone to Die in Month After Heart Attack  -  ‎Aug 25, 2009‎
A second report in the same issue of the journal described a genetic variant that can limit the effectiveness of Plavix (clopidogrel), the clot-preventing Atlanta Journal Constitution

A cure, but not for all  -  ‎Aug 28, 2009‎
The drug, which also goes by the name Plavix, is used in a range of heart diseases as well as for circulatory conditions and in the treatment of stroke. New Zealand Herald

Bristol-Myers spent $809K lobbying gov't in 2Q  -  ‎Aug 24, 2009‎
In April-June period, the maker of blockbuster anti-clotting treatment Plavix lobbied Congress on various aspects of health care reform. Forbes

Ask The Doctor: Will a Memory-Boosting Supplement Interfere With ...  -  ‎Aug 26, 2009‎
Plavix and aspirin prevent the formation of blood clots, which can trigger a heart attack or stroke. The American Heart Association recommends fish oil for KFSM

Sanofi, Watson Resolve Patent Dispute Over Plavix  -  ‎Aug 12, 2009‎
Inc. in a long-standing patent infringement suit over Watson's attempt to market a generic version of the blockbuster blood thinner Plavix. IP Law360 (subscription)

Portola Pharmaceuticals Announces Two Oral Presentations on ...  -  ‎Aug 24, 2009‎
Because of its properties, elinogrel has the potential to provide significant clinical advantages compared to Plavix(R)* (clopidogrel), the current standard PR Newswire (press release)

Stretching the healthcare dollar  -  ‎Aug 29, 2009‎
The usual dual anti-platelet therapy is aspirin (there are many generic forms) and clopidogrel (brand name Plavix). There are many studies to show that Malaysia Star

Beyond the Abstract - External beam radiotherapy for prostate ...  -  ‎Aug 24, 2009‎
We investigated the prevalence and severity of bleeding toxicity from prostate cancer radiotherapy among patients who are on Coumadin or Plavix. UroToday

2011 to 2015 will mark a period of high volatility as Plavix and ...  -  ‎Aug 24, 2009‎
The years 2011 to 2015 will mark a period of high volatility in the cardiovascular market as key products - including blockbusters Plavix and Lovenox - face PR-Inside.com (Pressemitteilung)

Saving on prescription drugs  -  ‎Aug 25, 2009‎
..."For example, 90-day supply of Plavix, an anti-platelet agent used to prevent stroke or heart attack that has no generic available inside the United States South Shore News and Tribune

Boycotting Glenn Beck's sponsors is not enough  -  ‎Aug 26, 2009‎
RadioShack, Sprint, CVS, Red Lobster, Nestle, Progressive Insurance and pharmaceutical companies Roche and Sanofi-Aventis (maker of Plavix). Chicago Defender

US Stocks Fall as Merck's Drop Outweighs Technology's Gain  -  ‎Aug 28, 2009‎
Bristol- Myers Squibb Co., the maker of anti-clotting drug Plavix, slid 2.9 percent to $22.12 after Morgan Stanley lowered its rating to “equal-weight,� Bloomberg

PREVIEW-Astra, Boehringer may steal show at heart congress  -  ‎Aug 24, 2009‎
N: Quote, Profile, Research) Plavix, while Boehringer will showcase Pradaxa. In both cases, billions of dollars are at stake. Continued Reuters India

(California) If only CalPERS' boss and board and flack were as ...  -  ‎Aug 11, 2009‎
...[/i] plavix without a prescription. plavix online consultation. A or performed to diagnose uterine fibroids through other types of antibiotics. plavix blue. Politicker

Wall Street Betrayal Seen in $4.8 Billion Company Debt Losses  -  ‎Aug 28, 2009‎
The maker of Plavix, the world's second best-selling medicine behind Pfizer Inc.'s Lipitor, continues to hold $169 million worth of auction-rate bonds. Bloomberg

A strong dollar isn't always a good thing  -  ‎Aug 17, 2009‎
It may not be as big a household name as Lipitor or Plavix, but it generated $2.9 billion in the first half of the year. Still, just like Lipitor and Plavix Tulsa World

The Empty Medicine Cabinet  -  ‎Aug 21, 2009‎
...s blood thinner Plavix will lose patent protection in 2011, Merck & Co.'s allergy and asthma medicine Singulair patent expires in 2012 and Eli Lilly & Co. Conde Nast Portfolio

Actual 'end of life' reveals health system flaws  -  ‎Aug 16, 2009‎
She was taking Plavix, another well-advertised drug, as a preventive measure after a heart procedure two years ago. Plavix is an anti-coagulant which Sarasota Herald-Tribune

Adding to Two Positions  -  ‎Aug 19, 2009‎
...and that figure will expand in 2011-2012 as some of the largest branded drugs face patent expiration -- Lipitor, Plavix and Singulair. TheStreet.com (subscription)

BMS Had $400M Motive to Use Healthcare Town Hall Rioters  -  ‎Aug 12, 2009‎
...received a windfall of $400 million, including over $200 million in additional revenue from sales of its heart-attack and stroke medication Plavix. BNET

Following his recent heart attack, Rifle man makes some necessary ...  -  ‎Aug 9, 2009‎
It's 4:45 am, Paul Rice climbs out of bed, eats a healthy breakfast and sucks down a handful of pills — Plavix, Aspirin, fish oil, niacin … the list goes on Glenwood Springs Post Independent

Angina: Don't Ignore This Major Risk Factor for a Heart Attack  -  ‎Aug 7, 2009‎
Tried-and-true aspirin is the antiplatelet workhorse, but clopidogrel (Plavix) has come on strong as an alternative, especially for people who don't respond KFSM

Going, going, gone Patents set to expire soon on many brand-name drugs  -  ‎Aug 7, 2009‎
Off patent in 2011: Advair, Plavix, Zyprexa, Effexor XR, Aprovel, Xalatan, Astelin, Synarel, Actos, Follistim, Viramune. Off patent in 2012: Crestor, Modern Medicine

CVS Caremark stock appears undervalued - Barron's  -  ‎Aug 23, 2009‎
N) anti-blood clotting medication Plavix. Meanwhile, the newspaper said results at CVS' 6900 retail stores appear strong, including a 6.1 percent increase Reuters

This One's Growing Through the Recession  -  ‎Aug 26, 2009‎
...a study was published about a genetic variation that predicts the response to Bristol-Myers Squibb (NYSE: BMY) and sanofi-aventis' (NYSE: SNY) Plavix. Motley Fool

CAFTA Raises Prices, Limits Availability of Life Saving Drugs for ...  -  ‎Aug 25, 2009‎
This was the case with the brand name drug Plavix, made by New Jersey based Sanofi-Aventis. Plavix is prescribed to prevent heart attacks and is currently Common Dreams (press release)

Irregular heartbeats could indicate risk of stroke  -  ‎Aug 28, 2009‎
...atrial fibrillation is identified as the cause, usually involves anti-clotting medications like aspirin, clopidogrel (Plavix) or warfarin (Coumadin). News 8 Austin

The country could live without watching those TV drug ads  -  ‎Aug 11, 2009‎
For Plavix, the cholesterol inhibitor, it was $170 million. Neither figure is advertising peanuts. But the industry says those costs for promoting their The News Journal

Weekly Roundup  -  ‎Aug 28, 2009‎
Over $12 billion in branded drug sales will go generic this year with Lipitor and Plavix following in 2011-2012. These are big tailwinds for the industry TheStreet.com (subscription)

MS: Health News  -  ‎Aug 6, 2009‎
A recent Kaiser report showed that the 10 brand-name drugs most commonly prescribed for Medicare beneficiaries — drugs such as Lipitor, Plavix or Prevacid, The Capitol Fax Blog

Brand Names/Synonyms:
Plavix is also known by the following brand names and/or synonymsCLOPIDOGREL SULFATE; Clopidogrel; Clopidogrel [Ban:Inn]; Plavix

Drug Category:
Plavix is categorized under the following by the FDA: Antiplatelet Agents; Platelet Aggregation Inhibitors; Fibrinolytic Agents; ATC:B01AC04

Dosage Forms:
round, biconvex, film- coated tablet

Absorption:
at least 50%

Interactions:
Aspirin, warfarin, heparin, NSAIDs



Chemical IUPAC Name:
methyl2-(2-chlorophenyl)-2-(7-thia-3-azabicyclo[4.3.0]nona-8,10-dien-3-yl)ethanoate

:
 
Web health.mongabay.com/health


Health Home | Conditions | Cancer | Medications | Surgery | Vaccines

mongabay.com


Disclaimer:

Contact a physician with regard to health concerns. Email requests for further health information will be discarded.

The materials contained on this Web site are for informational purposes only and do not constitute health or medical advice. Use of information on this site does not create or constitute any kind of agreement or contract between you and the owners or users of this site, the owners of the servers upon which it is housed, or anyone else who is in any way connected with this site.

Many links on health.mongabay.com/health lead to other sites. health.mongabay.com/health does not sponsor, endorse or otherwise approve of the materials appearing in such sites. Nor is health.mongabay.com/health responsible for dead or misdirected links.

IF YOU NEED A LINK/TEXT REMOVED FROM THIS PAGE, PLEASE CONTACT: mongabay (at) gmail.com


COPYRIGHT 2007 MONGABAY.COM